Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene

Autor Tschope, C. Google Scholar
Walther, T. Google Scholar
Koniger, J. Google Scholar
Spillmann, F. Google Scholar
Westermann, D. Google Scholar
Escher, F. Google Scholar
Pauschinger, M. Google Scholar
Pesquero, J. B. Autor UNIFESP Google Scholar
Bader, M. Google Scholar
Schultheiss, H. P. Google Scholar
Noutsias, M. Google Scholar
Instituição Free Univ Berlin
Universidade Federal de São Paulo (UNIFESP)
Max Delbruck Ctr Mol Med
Resumo Diabetic cardiomyopathy includes fibrosis. Kallikrein (KLK) can inhibit collagen synthesis and promote collagen breakdown. We investigated cardiac fibrosis and left ventricular (LV) function in transgenic rats (TGR) expressing the human kallikrein 1 (hKLK1) gene in streptozotocin (STZ) - induced diabetic conditions. Six weeks after STZ injection, LV function was determined in male Sprague-Dawley (SD) rats and TGR(hKLK1) (n = 10/group) by a Millar tip catheter. Total collagen content ( Sirius Red staining) and expression of types I, III, and VI collagen were quantified by digital image analysis. SD-STZ hearts demonstrated significantly higher total collagen amounts than normoglycemic controls, reflected by the concomitant increment of collagen types I, III, and VI. This correlated with a significant reduction of LV function vs. normoglycemic controls. in contrast, surface-specific content of the extracellular matrix, including collagen types I, III, and VI expression, was significantly lower in TGR( hKLK1)- STZ, not exceeding the content of SD and TGR( hKLK1) controls. This was paralleled by a preserved LV function in TGR( hKLK1)- STZ animals. the kallikrein inhibitor aprotinin and the bradykinin (BK) B2 receptor antagonist icatibant reduced the beneficial effects on LV function and collagen content in TGR( hKLK1)- STZ animals. Transgenic expression of hKLK1 counteracts the progression of LV contractile dysfunction and extracellular matrix remodeling in STZ-induced diabetic cardiomyopathy via a BK B2 receptor-dependent pathway.
Palavra-chave diabetes mellitus
diabetic cardiomyopathy
kallikrein
pathogenesis
therapy
transgenic animal
Idioma Inglês
Data de publicação 2004-05-01
Publicado em Faseb Journal. Bethesda: Federation Amer Soc Exp Biol, v. 18, n. 7, p. 828-835, 2004.
ISSN 0892-6638 (Sherpa/Romeo, fator de impacto)
Publicador Federation Amer Soc Exp Biol
Extensão 828-835
Fonte http://dx.doi.org/10.1096/fj.03-0736com
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000221883200031
Endereço permanente http://repositorio.unifesp.br/handle/11600/27718

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta